New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
09:21 EDTATHN, MCK, VCRA, MRGE, UNHBarclays to host events at HIMSS 2013
Company events being held in conjunction with HIMSS 2013 in New Orleans on March 4-5.
News For MRGE;MCK;UNH;VCRA;ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
09:09 EDTVCRAVocera participates in a conference call with Leerink
Subscribe for More Information
May 15, 2015
16:58 EDTMRGEMerge Healthcare files to sell 12.08M shares of common stock for holders
Subscribe for More Information
12:13 EDTMCKThird Point gives quarterly update on stakes
NEW STAKES: Yum! Brands (YUM), NXP Semiconductors (NXPI), FedEx (FDX), McKesson (MCK), and J M Smucker (SJM). INCREASED STAKES: Actavis (ACT), Roper Technologies (ROP), Delta Air Lines (DAL), and FleetCor Technologies (FLT). DECREASED STAKES: Ally Financial (ALLY), Amgen (AMGN), Phillips 66 (PSX), eBay (EBAY), and Anheuser Busch Inbev SA (BUD). LIQUIDATED STAKES: Alibaba Group (BABA), Citigroup (C), EMC Corporation (EMC), Anglo American (AAL), and Williams Companies (WMB).
12:07 EDTMCKThird Point reports new stakes in Yum! Brands, FedEx, McKesson
May 14, 2015
07:33 EDTUNHUnitedHealth would consider Optum spinoff if benefits erode, says UBS
Subscribe for More Information
May 13, 2015
10:07 EDTMCKHigh option volume stocks
Subscribe for More Information
09:56 EDTMCKEquity options with increasing volume
Subscribe for More Information
08:54 EDTMCKMcKesson price target raised to $252 from $234 at Cowen
Subscribe for More Information
07:55 EDTMCKMcKesson Q4 results 'outstanding,' says Baird
Subscribe for More Information
07:31 EDTMCKHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
May 12, 2015
16:20 EDTMCKMcKesson authorizes $500M repurchase program
Subscribe for More Information
16:18 EDTMCKMcKesson sees FY16 EPS $12.20-$12.70, consensus $12.57
Sees FY16 distribution solutions revenue growth in mid-single digits. Sees North America pharmaceutical distribution and services delivering high-single digit revenue growth. Sees international pharmaceutical and distribution services revenues flat year-over-year on constant currency basis. Sees medical-surgical distribution and services delivering mid-single digit revenue growth. Sees branded drug price trends in U.S. similar to FY15. Sees price trends on generic drugs outside an exclusivity period, in the U.S. market, slightly below FY15. Sees profit contribution from launch of new oral generic pharmaceuticals in the U.S. market decreasing. Sees technology solutions revenue declining mid-single digits driven by revenue decline in our hospital software business and pending sale of a business line. Guidance assumes adjusted tax rate 31.5%. Sees cash flow from operations $3B.
16:14 EDTMCKMcKesson reports Q4 adjusted adjusted EPS $2.94, consensus $2.75
Subscribe for More Information
15:00 EDTMCKNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include McKesson (MCK), consensus $2.75... Zillow (Z), consensus (12c)... GoDaddy (GDDY), consensus 35c... RSP Permian (RSPP), consensus 17c... Parsley Energy (PE), consensus 0c... Vivint Solar (VSLR), consensus (38c)... New Relic (NEWR), consensus (25c)... Hortonworks (HDP), consensus (86c)... SunOpta (STKL), consensus 7c... OPOWER (OPWR), consensus (16c)... JP Energy Partners (JPEP), consensus (4c)... TubeMogul (TUBE), consensus (18c)... Ducommun (DCO), consensus 30c.
07:56 EDTMCKMcKesson has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO John Hammergren on May 13 at 10:30 am.
May 11, 2015
07:40 EDTUNHFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertexís Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasnít announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
07:13 EDTUNHUnitedHealth management to meet with UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use